What is the evidence on legal measures to improve the transparency of markets for medicines, vaccines and other health products (World Health Assembly resolution WHA72.8)?

What is the evidence on legal measures to improve the transparency of markets for medicines, vaccines and other health products (World Health Assembly resolution WHA72.8)?

In 2019 the Seventy-second World Health Assembly endorsed resolution WHA72.8 to improve the transparency of markets for health products. This scoping review aims to support policy-makers in the WHO European Region who seek to develop policies related to market transparency by summarizing the current...

Descripción completa

Detalles Bibliográficos
Otros Autores: Perehudoff, Katrina, author (author), Mara, Kaitlin, author, 't Hoen, Ellen F. M., author
Formato: Libro electrónico
Idioma:Inglés
Publicado: Copenhagen, Denmark : HEN, Health Evidence Network, WHO Regional Office for Europe 2021.
Colección:Health Evidence Network synthesis report ; Number 73.
Materias:
Pharmaceutical industry > Moral and ethical aspects.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009816687006719
Tabla de Contenidos:
  • Expand AllCollapse All
  • ABBREVIATIONS
  • ACKNOWLEDGEMENTS
  • SUMMARY
  • 1. INTRODUCTION
  • 1.1. Background
  • 1.2. Methodology
  • 2. RESULTS
  • 2.1. Existing laws/mechanisms to improve the transparency of pharmaceutical markets
  • 2.2. Impact of laws/mechanisms on the transparency of pharmaceutical markets
  • 3. DISCUSSION
  • 3.1. Strengths and limitations of this review
  • 3.2. Improving the transparency of pharmaceutical markets
  • 3.3. Policy considerations
  • 4. CONCLUSIONS
  • REFERENCES
  • ANNEX 1. SEARCH STRATEGY
  • ANNEX 2. GLOSSARY
  • ANNEX 3. EXAMPLES OF NATIONAL LEGISLATION SUPPORTING THE TRANSPARENCY OF R&D COSTS OF MEDICINES, VACCINES AND MEDICAL PRODUCTS.

Ejemplares similares